间质性肺病的气溶胶输送--突破还是迷途？

IF 5 2区医学 Q1 PHARMACOLOGY & PHARMACY

Expert Opinion on Drug Delivery Pub Date : 2024-04-29 DOI:10.1080/17425247.2024.2348659

Carsten Ehrhardt

引用次数: 0

摘要

发表于《给药专家意见》（2024 年，印刷版前）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Aerosol delivery in interstitial lung diseases - breakthrough or lost cause?

Published in Expert Opinion on Drug Delivery (Ahead of Print, 2024)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Expert Opinion on Drug Delivery 医学-药学

CiteScore

11.10

自引率

3.00%

发文量

104

审稿时长

3 months

期刊介绍： Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.